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Herpes simplex viruses (HSV) are resistant to the antiviral action of interferon. However, the underlying mechanisms are
not well understood. In this report, we show that unlike that of wild-type HSV-1, replication of the g134.5 null mutants was
significantly inhibited by exogenous interferon-a in cells devoid of interferon-a/b genes. Using a series of g134.5 deletion
mutants, the domain required for interferon resistance was mapped to the region containing amino acids 146 to 263 in the
g134.5 protein. Interestingly, Val
193Glu and Phe195Leu substitutions in the protein phosphatase 1 interacting motif of the g134.5
protein rendered HSV-1 sensitive to interferon-a. Furthermore, g134.5 null mutants were sensitive to interferon-a/b in
PKR1/1 but not in PKR2/2 mouse embryo fibroblasts. These findings provide evidence that the g134.5 protein contributes
to HSV-1 resistance to interferon-a/b by inhibiting PKR function. © 2001 Academic Press
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eINTRODUCTION
Herpes simplex viruses (HSV) are human pathogens
that are resistant to interferon (Arao et al., 1997; De
Stasio and Taylor, 1990; Oberman and Panet, 1988). Two
lines of genetic evidence indicated that different regions
of the HSV-2 genome are associated with interferon
resistance (Narita et al., 1998; Su et al., 1993). One region
ontains genes encoding UL14, UL15, and UL16 (Su et
l., 1993). Another region encompasses genes encoding
L40, UL41, and UL42 (Narita et al., 1998). Recently, ICP0
of HSV-1 was reported to be involved in HSV-1 resistance
to the antiviral effects of interferon (Mossman et al.,
2000). Deletions in the ICP0 gene dramatically increased
the sensitivity of HSV-1 to interferon. Early studies sug-
gested that interferon could specifically target translation
of HSV proteins (Altinkilic and Brandner, 1988; Lipp and
Brandner, 1980). Subsequent investigations showed that
interferon decreases expression of HSV a genes (De
tasio and Taylor, 1990; Nicholl and Preston, 1996; Ober-
an and Panet, 1988, 1989). The effects of interferon on
SV appear to be cell type dependent (De Stasio and
aylor, 1990; Taylor et al., 1998). It was suggested that
SV inhibits the 29-59 oligoadenylate synthetase path-
ay by producing a 29-59 oligoadenylate analogue (Cay-
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology and Immunology (M/C 790),
ollege of Medicine, The University of Illinois at Chicago, 835 Southr
olcott Avenue, Chicago, IL 60612. Fax: (312) 996-6415. E-mail:
shuo@uic.edu.
115ley et al., 1984). While these observations are intriguing,
the underlying mechanisms remain obscure.
To understand the HSV resistance to interferon, we
sought to examine the role of the g134.5 gene, which
encodes a protein of 263 amino acids (Chou and Roiz-
man, 1990). Mutants that fail to express the g134.5 pro-
ein are incapable of replicating and causing encephali-
is in mice (Chou et al., 1990). In human cell lines infected
ith the g134.5 null mutants, initiation of viral replication
riggers the global shutoff of protein synthesis mediated
y double-stranded RNA-dependent protein kinase PKR
Chou et al., 1995; Chou and Roizman, 1992). We have
ecently shown that in cells infected with HSV-1 the
g134.5 protein binds to cellular protein phosphatase 1
PP1), forming a high-molecular-weight complex that de-
hosphorylates the a subunit of translation initiation fac-
tor eIF-2 (He et al., 1998). Interestingly, completely differ-
ent phenotypes have been reported for the g134.5 null
utants in experimental mice (Leib et al., 2000; Mohr et
l., 2001). The g134.5 null mutant is virulent in PKR2/2
ice but not in wild-type mice (Leib et al., 2000). How-
ver, the g134.5 null mutant, with secondary mutations in
the Us11 region, inhibited PKR activity but exhibited an
avirulent phenotype in wild-type mice (Mohr et al., 2001).
These observations raise the question of the biological
functions of g134.5 in HSV infection.
In this report, we show that the g134.5 null mutants are
hypersensitive to interferon treatment. We further dem-
onstrate that the domain containing amino acids 146 to
193 195263, particularly Val and Phe , in the g134.5 protein is
equired for viral resistance to interferon-a/b. Our stud-
0042-6822/01 $35.00
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116 CHENG, BRETT, AND HEies suggest that inhibition of PKR activity by the g134.5
protein contributes to the HSV-1 resistance to interferon
in infected cells.
RESULTS
The g134.5 deletion mutant is sensitive to interferon-
a/b in cell culture
In order to investigate whether the deletion of the
g134.5 gene has any effect on HSV-1 resistance to inter-
eron, we examined, in Vero cells, the replication of
ild-type HSV-1(F) and the g134.5 deletion mutant R3616,
in which the entire coding region of the g134.5 gene has
een deleted (Chou et al., 1990). Specifically, monolayers
f Vero cells were untreated or pretreated with human
eukocyte interferon-a (1000 U/ml) for 20 h, and cells
were then infected with HSV-1(F) or R3616 at 0.05 PFU
FIG. 1. Effect of interferon (IFN) on viral replication in Vero cells.
Monolayers of Vero cells were untreated (A) or pretreated (B) with
human leukocyte interferon-a (1000 U/ml) for 20 h. Cells were then
infected with wild-type virus HSV-1(F), R3616 (Chou et al., 1990) virus in
which the entire coding region of g134.5 was deleted, at 0.05 PFU per
ell and incubated at 37°C. At different time points postinfection, virus
ield was determined on Vero cells as described under Materials and
ethods. Duplicate samples were analyzed in parallel at each time
oint, and the data represent the average from three independent
xperiments with a standard deviation.per cell. At different time points after infection, the cells
were harvested and virus yields were measured byplaque assays. The results presented in Fig. 1A show
that in cells untreated with interferon, HSV-1(F) reached
the peak titer of 7.8 3 107 PFU/ml at 24 h postinfection,
with a 2 log increase in growth. Virus titer remained at a
similar level throughout the infection period. Similarly,
R3616 reached a titer of 3.6 3 106 PFU/ml over the same
time period. Under these conditions, growth of HSV-1(F)
was approximately 20-fold better than that of R3616 (Fig.
1A). Interestingly, in cells pretreated with interferon (Fig.
1B), HSV-1(F) still replicated efficiently, achieving a titer
of 2.6 3 107 PFU/ml at 24 h postinfection. In sharp
contrast, in Vero cells pretreated with interferon-a,
growth of R3616 was drastically inhibited, with viral titer
reduced to approximately 2.0 3 103 PFU/ml at 24 h
postinfection. Virus yield for this mutant was 1000-fold
less than that seen in cells untreated with interferon-a
(Figs. 1A and 1B). These results demonstrate that addi-
tion of exogenous interferon-a to Vero cells significantly
inhibits replication of the g134.5 null mutants but not
wild-type HSV-1(F), indicating that the g134.5 protein is
equired to confer HSV-1 resistance to interferon.
he domain containing amino acids 146 to 263 is
rucial for HSV-1 resistance to interferon-a/b
To determine the domain of the g134.5 protein that is
required for interferon resistance, a series of deletion
mutants of g134.5 was used to infect Vero cells. Vero
cells were untreated or pretreated with interferon-a for
20 h and subsequently infected with a serial dilution of
each virus. Ninety-six hours after infection, the plaque
numbers were determined and the results are presented
as the ratio of plaque numbers without and with inter-
feron treatment. The data summarized in Table 1 indicate
TABLE 1
Effect of Interferon-a on Plaque Formation of g134.5 Deletion
Mutants in Vero Cellsa
Viruses g134.5 gene
Virus titer ratio
(2IFN-a/1IFN-a)
HSV-1(F) Wild type 4.5 6 0.1
R3616 Deletion of entire coding region (8.2 6 2.9)3104
H9813 Val193Glu, Phe195Leu substitutions (5.6 6 0.6)3105
R4002 Deletion of amino acids 1–30 12.4 6 2.3
R931 Deletion of amino acids 31–72 19.0 6 3.9
R908 Deletion of amino acids 72–106 11.3 6 0.8
R909 Deletion of amino acids 107–146 9.0 6 0.1
R8301 Deletion of amino acids 206–263 (2.2 6 0.7)3105
a Vero cells were untreated or pretreated with 1000 U/ml human
eukocyte interferon-a(sigma), for 20 h. Cells were then infected with a
serial dilution of the indicated viruses. Plaque numbers were deter-
mined and the results are presented as the ratio of viral titer in the
absence and in the presence of interferon-a. Duplicate samples were
analyzed in parallel and the data represent assays from three indepen-
dent experiments with the standard deviation indicated.
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117HSV-1 RESISTANCE TO INTERFERON-a/bthat plaque formation for wild-type HSV-1(F) was slightly
reduced by interferon-a (5-fold), whereas plaque forma-
tion of the g134.5 deletion mutant R3616 was reduced by
10,000-fold. These results are consistent with experimen-
tal data presented in Figs. 1A and 1B. Importantly, for
deletion mutants R4002, R908, R909, and R931 (Chou and
Roizman, 1994; He et al., 1998), plaque formation was
reduced only 10- to 20-fold, exhibiting a relative resistant
phenotype to interferon-a. These mutants have deletions
in amino acids 1 to 146 of the g134.5 protein (Table 1). In
ontrast, like that of R3616, plaque formation for mutant
8301, with a deletion of amino acids 206 to 263 (He et
l., 1996), was dramatically reduced in response to inter-
eron treatment. This mutant was inhibited more than
0,000-fold. Remarkably, H9813, which has Val193Glu and
Phe195Leu substitutions in the PP1 interacting motif of the
g134.5 protein (Cheng et al., 2001), was also inhibited to
a similar extent. These data demonstrate that while
amino acids 1 to 146 in the g134.5 protein are dispens-
able, amino acids 205 to 263, notably Val193 and Phe195,
re essential for interferon resistance.
eplication of the g134.5 null mutants is not affected
y interferon-a/b in PKR2/2 mouse embryo
fibroblasts
We next examined whether sensitivity of the g134.5
null mutants to interferon is directly linked to PKR. The
phenotypes of HSV-1(F), R3616, and H9813 were ana-
lyzed in embryo fibroblasts derived from PKR1/1 and
KR2/2 mice (Der et al., 1997; Yang et al., 1995). As
shown in Fig. 2, PKR is expressed at a low level but
induced by interferon in PKR1/1 cells. As expected, no
PKR was detected in PKR2/2 cells. Based on this ob-
servation, we next examined replication of wild-type vi-
rus and the g134.5 null mutants. Monolayers of PKR1/1
and PKR2/2 cells were untreated or pretreated with
mouse interferon-a/b (1000 U/ml) for 20 h. Cells were
FIG. 2. Expression of PKR in embryo fibroblasts derived from
PKR1/1 and PKR2/2 mice. Monolayers of cells were untreated or
reated with mouse interferon-a/b (IFN) (1000 U/ml) for 20 h. Cell
xtracts were then prepared and subjected to electrophoresis on 12%
DS–PAGE, transferred to a nitrocellulose membrane, and subjected to
mmunoblot with monoclonal antibody to mouse PKR (Santa Cruz Bio-
echnologies) as described under Materials and Methods.hen infected with HSV-1 (F), R3616, or H9813 at 0.05 PFU
er cell. At 48 h postinfection, cells were harvested anditrated on Vero cells. As shown in Fig. 3A, in the
KR1/1 cell line untreated with interferon, HSV-1(F) rep-
licated to 1.2 3 107 PFU/ml, R3616 reached a titer of only
.0 3 104 PFU/ml, and H9813 reached a titer of 4.0 3 105
PFU/ml. When PKR1/1 cells were pretreated with inter-
feron, the titer of HSV-1(F) decreased slightly. However,
the titer of R3616 or H9813 further decreased approxi-
mately 1000-fold. This result correlated with the in-
creased level of PKR induced by interferon-a/b (Fig. 2).
Figure 3B indicates that in PKR2/2 knockout cells, rep-
ication of HSV-1(F), R3616, or H9813 is not affected by
nterferon-a/b. Immunoblot analysis confirmed that the
g134.5 protein was expressed in cells infected with HSV-
(F) or H9813 (data not shown). The data indicate that
FIG. 3. (A) Effect of interferon (IFN) on replication of HSV-1(F), R3616,
or H9813 in PKR1/1 cells. Monolayers of PKR1/1 mouse fibroblasts
were untreated or pretreated with mouse interferon-a/b (1000 U/ml) for
20 h. Cells were then infected with wild-type virus HSV-1(F), R3616 virus
in which the entire coding region of g134.5 was deleted, or H9813 in
hich Val193 and Phe195 were replaced by Glu and Leu, respectively
(Cheng et al., 2001), at 0.05 PFU per cell and incubated at 37°C. At 48 h
postinfection, cells were harvested and freeze-thawed three times, and
virus yield was determined on Vero cells. (B) Effect of interferon on
replication of HSV-1(F), R3616, or H9813 in PKR2/2 cells. Assay con-
ditions are the same as described in (A) except that PKR2/2 embryo
fibroblasts were used. The data are the average of three independent
experiments with a standard deviation.
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118 CHENG, BRETT, AND HEPKR is a cellular target of the g134.5 protein. Taken
ogether, we conclude that HSV-1 resistance to interferon
s linked to the ability of the g134.5 protein to inhibit PKR
unction.
DISCUSSION
It is generally considered that interferon is not very
ffective in limiting HSV infections due to natural resis-
ance of HSV to interferon. Studies suggest that several
actors or regions of HSV are involved but the mecha-
isms remain unknown (Mossman et al., 2000; Narita et
l., 1998; Su et al., 1993). Our results indicate that the
g134.5 protein is a viral factor that renders HSV-1 resis-
ant to interferon-a in infected cells.
The data shown in Fig. 1 indicate a direct link between
the g134.5 gene and the HSV-1(F) resistance to inter-
feron. The marginal reduction of the HSV-1(F) titer may
reflect the resistant nature of HSV to the antiviral effects
of interferon. Notably, in response to interferon-a treat-
ent, replication of R3616 was inhibited more than 1000-
old (Fig. 1B). We recently found that replication of R3616
as severely impaired in human neuroblastoma cells for
hich no defect in interferon genes has been reported
Cheng et al., 2001). Interestingly, in untreated Vero cells
Fig. 1A), which are devoid of interferon-a/b genes (Diaz
et al., 1988), replication of R3616 increased moderately
(10-fold), suggesting that a deficiency of endogenous
interferon likely contributes to the observed phenotype.
However, as shown in Fig. 1A, replication of R3616 was
not as efficient as that of HSV-1(F) in untreated Vero cells.
At 24 h postinfection, growth of R3616 was approximately
20-fold less than that for HSV-1(F). A similar phenotype
was observed in the U87MG cell line, which has dele-
tions in interferon-a/b genes (data not shown). The basis
or this remains unknown. We speculate that the g134.5
eletion mutant is unable to block a cellular response
hat is independent of interferon-a/b. In fact, recent stud-
ies suggest that HSV-1 infection elicits an interferon-
independent antiviral state in the absence of viral gene
expression (Mossman et al., 2001). It is likely that HSV-1
encodes more than one protein to counteract cellular
antiviral defense. It remains to be established what role,
if there is any, the g134.5 protein has in this process.
It should be pointed out that the domain containing
amino acids 205 to 263 in the g134.5 protein of HSV-1 is
also conserved in HSV-2 (Chou and Roizman, 1994). This
region is highly homologous to the corresponding region
of the NL protein from African swine fever virus (Suss-
man et al., 1992) and of cellular GADD34, which is ex-
pressed during growth arrest, differentiation, and apo-
ptosis (Hollander et al., 1997; Zhan et al., 1994). The
onserved domain may represent a functional module
hat antagonizes the effects of interferon involved in virus
nfection as well as in cellular growth regulation. Previ-us studies have shown that mutants with deletions in
mino acids 1 to 146 of g134.5 are able to prevent the
shutoff of protein synthesis, whereas mutants with trun-
cations of amino acids 205 to 263 or Val193Glu and
Phe195Leu substitutions in the g134.5 protein fail to pre-
vent the shutoff of protein synthesis in human cell lines
(Chou and Roizman, 1994; He et al., 1998). In light of
these observations, we are intrigued by the findings that
sensitivity of the g134.5 mutants to interferon-a corre-
lated well with the ability of the g134.5 protein to prevent
he shutoff of protein synthesis in HSV-infected cells. The
esponse of H9813 to interferon is of particular interest.
n previous studies we observed that H9813 failed to
ediate dephosphorylation of eIF-2a (Cheng et al.,
2001). In addition, the phenotypes associated with H9813
suggest that the ability of g134.5 protein to reverse PKR-
mediated eIF-2a phosphorylation is required for HSV
resistance to interferon.
Recent experiments have shown that HSV mutants
with defects in UL23, UL39, ICP0, or the g134.5 gene
isplayed enhanced replication in interferon-receptor
nockout mice (Leib et al., 1999). The effects of inter-
eron-receptor knockout mice appeared to be not spe-
ific to g134.5 mutants. Interestingly, the g134.5 null mu-
tant is virulent in PKR2/2 mice but not wild-type mice
(Leib et al., 2000). Given the involvement of PKR in the
inflammatory response and possibly other elements of
systemic immunity, our studies extended these findings
by showing that functional interactions of Val193 and
he195 in the g134.5 protein with PKR, in large part, de-
termine the sensitivity of HSV-1 to interferon-a/b in HSV-
nfected cells (Fig. 3). The inhibitory effects of interferon
n R3616 and H9813 in PKR1/1 mouse embryo fibro-
lasts demonstrate that the g134.5 gene of HSV encodes
n antagonist of interferon (Fig. 3A). Notably, interferon-a
had no effect on the replication of R3616 and H9813 in
mouse embryo fibroblasts with the homozygous deletion
of PKR (Fig. 3B), indicating that the pathway controlled by
PKR is a target of g134.5. Since the interferon signaling
athways are intact in the PKR2/2 cell line (Yang et al.,
995), this result suggests that PKR is a dominant factor
hat mediates antiviral actions of interferon to HSV. It is
nteresting to note that in the absence of interferon treat-
ent, both R3616 and H9813 displayed growth defects
ompared to HSV-1(F) in PKR1/1 cells (Fig. 3A). This
ay be attributed to the expression of the basal level of
KR (Fig. 2) or induction of endogenous interferon by
SV infection. Interestingly, growth of H9813 is approxi-
ately 10-fold higher than that of R3616. One interpreta-
ion of these data is that deletion of the g134.5 gene
altered the expression of other HSV genes that contrib-
ute to the difference in viral replication. An alternative
hypothesis is that loss of additional functions associated
with g134.5 might be responsible for the observed differ-
ence. Interpreted in this context, it is interesting that
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119HSV-1 RESISTANCE TO INTERFERON-a/bmutations in the g134.5 gene affect the egress of HSV-1
r the ability of HSV-1 to invade the central nervous
ystem (Bower et al., 1999; Brown et al., 1994). Recent
tudies showed that the g134.5 null mutant, with second-
ry mutations in the Us11 region, inhibited PKR activity
ut exhibited an avirulent phenotype in wild-type mice
Mohr et al., 2001), suggesting that the g134.5 protein has
more than one function.
The g134.5 gene is a g (later) gene (Chou and Roiz-
man, 1986), but little is known about how its expression
is controlled during HSV-1 infection. Recent work shows
that the steady-state level of the g134.5 mRNA is de-
creased in HeLa cells infected with the ICP27 deletion
mutant (Stingley et al., 2000), suggesting a critical role for
the a gene in modulating the expression of the g134.5
gene. In this respect, it is interesting to note that ICP0
deletion mutants are hypersensitive to interferon (Moss-
man et al., 2000). A proposed model is that ICP0 is a viral
factor that directly targets the cellular components in-
duced by interferon (Mossman et al., 2000). Alternatively,
his phenotype could be an indirect result of reduced or
ailed expression of one or more viral proteins that are
ownstream in the lytic cycle. The fact that ICP0 is an a
gene raises the possibility that the g134.5 gene is a
otential regulatory target of ICP0. Further experiments
re required to test these hypotheses.
MATERIALS AND METHODS
ells and viruses
Vero cells were obtained from the American Type
ulture Collection. Mouse embryo fibroblasts were de-
ived from PKR1/1 and PKR2/2 mice. Cells were prop-
agated in Dulbecco’s modified Eagle’s medium supple-
mented with 5% fetal bovine serum and 5% CO2. HSV-1(F)
is a prototype HSV-1 strain used in these studies (Chou
and Roizman, 1994). In recombinant virus R3616, a 1-kb
fragment from the coding region of the g134.5 gene was
eleted (Chou et al., 1990). In recombinant virus H9813,
odons encoding Val193 and Phe195 of the g134.5 gene
were replaced with those encoding Glu and Leu, respec-
tively (Cheng et al., 2001). In recombinant virus R8301, the
39 sequence encoding amino acids 206 to 263 was
deleted from the carboxyl-terminus of the g134.5 gene
(He et al., 1996). In recombinant viruses R4002, R931,
R908, and R909, the sequences of the g134.5 gene en-
coding amino acids 1 to 30, 31 to 71, 72 to 106, and 107
to 146, respectively, were deleted (Chou and Roizman,
1994).
Plaque assay
Monolayers of cells grown to 80% confluency were
untreated or treated with interferon-a/b (1000 U/ml) for
20 h. Cells were then infected with viruses at 0.05 PFUper cell and incubated at 37°C. At different time points
postinfection, cells were harvested and freeze-thawed
three times, and virus yield was determined on Vero
cells.
Immunoblotting
Monolayers of cells were untreated or treated with
mouse interferon-a/b (1000 U/ml) for 20 h. The cells were
hen harvested, washed with phosphate-buffered saline,
nd resuspended in disruption buffer containing 50 mM
ris–HCl (pH 7.0), 5% 2-mercaptoethanol, 2% SDS, and
.75% sucrose. Cell extracts were prepared and sub-
ected to electrophoresis on 12% SDS–PAGE, transferred
o a nitrocellulose membrane, and subjected to immuno-
lot with monoclonal antibody to mouse PKR as sug-
ested by the manufacturer (Santa Cruz Biotechnolo-
ies).
ACKNOWLEDGMENTS
This work was supported by Grant AI 46665 from the National
Institute of Allergy and Infectious Diseases to B.H. We thank Dr. Ber-
nard Roizman for HSV mutants and Dr. Bryan R. G. William for mouse
embryo fibroblasts.
REFERENCES
Altinkilic, B., and Brandner, G. (1988). Interferon inhibits herpes simplex
virus-specific translation: A reinvestigation. J. Gen. Virol. 69(Pt. 12),
3107–3112.
Arao, Y., Ando, Y., Narita, M., and Kurata, T. (1997). Unexpected corre-
lation in the sensitivity of 19 herpes simplex virus strains to types I
and II interferons. J. Interferon Cytokine Res. 17(9), 537–541.
Bower, J. R., Mao, H., Durishin, C., Rozenbom, E., Detwiler, M., Rem-
pinski, D., Karban, T. L., and Rosenthal, K. S. (1999). Intrastrain
variants of herpes simplex virus type 1 isolated from a neonate with
fatal disseminated infection differ in the ICP34.5 gene, glycoprotein
processing, and neuroinvasiveness. J. Virol. 73(5), 3843–3853.
Brown, S. M., MacLean, A. R., Aitken, J. D., and Harland, J. (1994).
ICP34.5 influences herpes simplex virus type 1 maturation and
egress from infected cells in vitro. J. Gen. Virol. 75(Pt. 12), 3679–3686.
Cayley, P. J., Davies, J. A., McCullagh, K. G., and Kerr, I. M. (1984).
Activation of the ppp(A29p)nA system in interferon-treated, herpes
simplex virus-infected cells and evidence for novel inhibitors of the
ppp(A29p)nA-dependent RNase. Eur. J. Biochem. 143(1), 165–174.
heng, G., Gross, M., Brett, M. E., and He, B. (2001). AlaArg motif in the
carboxyl terminus of the g134.5 protein of herpes simplex virus type
1 is required for the formation of a high-molecular-weight complex
that dephosphorylates eIF-2a. J. Virol. 75(8), 3666–3674.
hou, J., Chen, J. J., Gross, M., and Roizman, B. (1995). Association of a
M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhib-
iting enhanced phosphorylation of translation initiation factor eIF-2a
and premature shutoff of protein synthesis after infection with
g134.5
2 mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA
92(23), 10516–10520.
Chou, J., Kern, E. R., Whitley, R. J., and Roizman, B. (1990). Mapping of
herpes simplex virus-1 neurovirulence to g134.5, a gene nonessen-
tial for growth in culture. Science 250(4985), 1262–1266.
Chou, J., and Roizman, B. (1986). The terminal a sequence of the herpes
simplex virus genome contains the promoter of a gene located in the
repeat sequences of the L component. J. Virol. 57(2), 629–637.
Chou, J., and Roizman, B. (1990). The herpes simplex virus 1 gene for
DD
D
H
M
M
N
N
O
O
S
S
S
T
Y
Z
120 CHENG, BRETT, AND HEICP34.5, which maps in inverted repeats, is conserved in several
limited-passage isolates but not in strain 17syn1. J. Virol. 64(3),
1014–1020.
Chou, J., and Roizman, B. (1992). The g134.5 gene of herpes simplex
virus 1 precludes neuroblastoma cells from triggering total shutoff of
protein synthesis characteristic of programmed cell death in neuro-
nal cells. Proc. Natl. Acad. Sci. USA 89(8), 3266–3270.
Chou, J., and Roizman, B. (1994). Herpes simplex virus 1 g134.5 gene
function, which blocks the host response to infection, maps in the
homologous domain of the genes expressed during growth arrest
and DNA damage. Proc. Natl. Acad. Sci. USA 91(12), 5247–5251.
er, S. D., Yang, Y. L., Weissmann, C., and Williams, B. R. (1997). A
double-stranded RNA-activated protein kinase-dependent pathway
mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94(7),
3279–3283.
e Stasio, P. R., and Taylor, M. W. (1990). Specific effect of interferon on
the herpes simplex virus type 1 transactivation event. J. Virol. 64(6),
2588–2593.
iaz, M. O., Ziemin, S., Le Beau, M. M., Pitha, P., Smith, S. D., Chilcote,
R. R., and Rowley, J. D. (1988). Homozygous deletion of the a and
b1-interferon genes in human leukemia and derived cell lines. Proc.
Natl. Acad. Sci. USA 85(14), 5259–5263.
He, B., Chou, J., Liebermann, D. A., Hoffman, B., and Roizman, B. (1996).
The carboxyl terminus of the murine MyD116 gene substitutes for the
corresponding domain of the g134.5 gene of herpes simplex virus to
preclude the premature shutoff of total protein synthesis in infected
human cells. J. Virol. 70(1), 84–90.
e, B., Gross, M., and Roizman, B. (1998). The g134.5 protein of herpes
simplex virus 1 has the structural and functional attributes of a
protein phosphatase 1 regulatory subunit and is present in a high
molecular weight complex with the enzyme in infected cells. J. Biol.
Chem. 273(33), 20737–20743.
Hollander, M. C., Zhan, Q., Bae, I., and Fornace, A. J., Jr. (1997). Mam-
malian GADD34, an apoptosis- and DNA damage-inducible gene.
J. Biol. Chem. 272(21), 13731–13737.
Leib, D. A., Harrison, T. E., Laslo, K. M., Machalek, M. A., Moorman, N. J.,
and Virgin, H. W. (1999). Interferons regulate the phenotype of wild-
type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189(4),
663–672.
Leib, D. A., Machalek, M. A., Williams, B. R., Silverman, R. H., and Virgin,
H. W. (2000). Specific phenotypic restoration of an attenuated virus by
knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97(11),
6097–6101.
Lipp, M., and Brandner, G. (1980). Inhibition of herpes simplex virus type
1 specific translation in cells treated with poly(rI).POLY(RC). J. Gen.
Virol. 47(1), 97–111.
Mohr, I., Sternberg, D., Ward, S., Leib, D., Mulvey, M., and Gluzman, Y.(2001). A herpes simplex virus type 1 g134.5 second-site suppressor
mutant that exhibits enhanced growth in cultured glioblastoma cells
is severely attenuated in animals. J. Virol. 75(11), 5189–5196.
ossman, K. L., Macgregor, P. F., Rozmus, J. J., Goryachev, A. B.,
Edwards, A. M., and Smiley, J. R. (2001). Herpes simplex virus triggers
and then disarms a host antiviral response. J. Virol. 75(2), 750–758.
ossman, K. L., Saffran, H. A., and Smiley, J. R. (2000). Herpes simplex
virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74(4),
2052–2056.
arita, M., Ando, Y., Soushi, S., Kurata, T., and Arao, Y. (1998). The
BglII-N fragment of herpes simplex virus type 2 contains a region
responsible for resistance to antiviral effects of interferon. J. Gen.
Virol. 79(Pt. 3), 565–572.
icholl, M. J., and Preston, C. M. (1996). Inhibition of herpes simplex
virus type 1 immediate-early gene expression by alpha interferon is
not VP16 specific. J. Virol. 70(9), 6336–6339.
berman, F., and Panet, A. (1988). Inhibition of transcription of herpes
simplex virus immediate early genes in interferon-treated human
cells. J. Gen. Virol. 69(Pt. 6), 1167–1177.
berman, F., and Panet, A. (1989). Characterization of the early steps of
herpes simplex virus replication in interferon-treated human cells.
J. Interferon Res. 9(5), 563–571.
tingley, S. W., Ramirez, J. J., Aguilar, S. A., Simmen, K., Sandri-Goldin,
R. M., Ghazal, P., and Wagner, E. K. (2000). Global analysis of herpes
simplex virus type 1 transcription using an oligonucleotide-based
DNA microarray. J. Virol. 74(21), 9916–9927.
u, Y. H., Oakes, J. E., and Lausch, R. N. (1993). Mapping the genetic
region coding for herpes simplex virus resistance to mouse inter-
feron a/b. J. Gen. Virol. 74(Pt. 11), 2325–2332.
ussman, M. D., Lu, Z., Kutish, G., Afonso, C. L., Roberts, P., and Rock,
D. L. (1992). Identification of an African swine fever virus gene with
similarity to a myeloid differentiation primary response gene and a
neurovirulence-associated gene of herpes simplex virus. J. Virol.
66(9), 5586–5589.
aylor, J. L., Little, S. D., and O’Brien, W. J. (1998). The comparative
anti-herpes simplex virus effects of human interferons. J. Interferon
Cytokine Res. 18(3), 159–165.
ang, Y. L., Reis, L. F., Pavlovic, J., Aguzzi, A., Schafer, R., Kumar, A.,
Williams, B. R., Aguet, M., and Weissmann, C. (1995). Deficient sig-
naling in mice devoid of double-stranded RNA-dependent protein
kinase. EMBO J. 14(24), 6095–6106.
han, Q., Lord, K. A., Alamo, I., Jr., Hollander, M. C., Carrier, F., Ron, D.,
Kohn, K. W., Hoffman, B., Liebermann, D. A., and Fornace, A. J., Jr.
(1994). The gadd and MyD genes define a novel set of mammalian
genes encoding acidic proteins that synergistically suppress cell
growth. Mol. Cell. Biol. 14(4), 2361–2371.
